Benjamin L. Ebert

153.3k total citations · 32 hit papers
294 papers, 73.5k citations indexed

About

Benjamin L. Ebert is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Benjamin L. Ebert has authored 294 papers receiving a total of 73.5k indexed citations (citations by other indexed papers that have themselves been cited), including 166 papers in Hematology, 164 papers in Molecular Biology and 94 papers in Genetics. Recurrent topics in Benjamin L. Ebert's work include Acute Myeloid Leukemia Research (126 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (64 papers) and Protein Degradation and Inhibitors (36 papers). Benjamin L. Ebert is often cited by papers focused on Acute Myeloid Leukemia Research (126 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (64 papers) and Protein Degradation and Inhibitors (36 papers). Benjamin L. Ebert collaborates with scholars based in United States, Germany and Sweden. Benjamin L. Ebert's co-authors include Todd R. Golub, Pablo Tamayo, Jill P. Mesirov, Michael A. Gillette, Aravind Subramanian, Vamsi K. Mootha, Sayan Mukherjee, Amanda G. Paulovich, Eric S. Lander and Scott L. Pomeroy and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Benjamin L. Ebert

286 papers receiving 72.7k citations

Hit Papers

Gene set enrichment analysis: A knowledge-based approach ... 1994 2026 2004 2015 2005 2005 2013 2013 2015 10.0k 20.0k 30.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
    2005 34.0k citations Benjamin L. Ebert, Todd R. Golub et al. profile →
  2. MicroRNA expression profiles classify human cancers
    2005 7.8k citations Justin Lamb, Benjamin L. Ebert et al. profile →
  3. Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells
    2013 3.7k citations Ophir Shalem, Neville E. Sanjana et al. Science profile →
  4. Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells
    2013 1.3k citations Jan Krönke, Namrata D. Udeshi et al. Science profile →
  5. Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
    2015 1.2k citations David P. Steensma, Rafael Bejar et al. Blood profile →
  6. Rational design of highly active sgRNAs for CRISPR-Cas9–mediated gene inactivation
    2014 1.2k citations John G. Doench, Ella Hartenian et al. profile →
  7. Clinical Effect of Point Mutations in Myelodysplastic Syndromes
    2011 1.1k citations Rafael Bejar, Kristen E. Stevenson et al. profile →
  8. MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid Metaplasia
    2006 1.0k citations Benjamin L. Ebert, Todd R. Golub et al. profile →
  9. Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia
    2010 798 citations Benjamin L. Ebert, Fátima Al‐Shahrour et al. profile →
  10. Stem cell gene expression programs influence clinical outcome in human leukemia
    2011 740 citations Todd R. Golub, Benjamin L. Ebert et al. profile →
  11. Perivascular Gli1+ Progenitors Are Key Contributors to Injury-Induced Organ Fibrosis
    2014 671 citations Rebekka K. Schneider, Benjamin L. Ebert et al. profile →
  12. Identification of RPS14 as a 5q- syndrome gene by RNA interference screen
    2008 629 citations Benjamin L. Ebert, Naomi Galili et al. profile →
  13. Clonal hematopoiesis in human aging and disease
    2019 595 citations Siddhartha Jaiswal, Benjamin L. Ebert Science profile →
  14. Acute myeloid leukemia ontogeny is defined by distinct somatic mutations
    2014 595 citations Peter Grauman, David P. Steensma et al. Blood profile →
  15. Ribosomopathies: human disorders of ribosome dysfunction
    2010 576 citations Anupama Narla, Benjamin L. Ebert Blood profile →
  16. ( R )-2-Hydroxyglutarate Is Sufficient to Promote Leukemogenesis and Its Effects Are Reversible
    2013 533 citations Ryan Looper, Peppi Koivunen et al. Science profile →
  17. Hypoxic Regulation of Lactate Dehydrogenase A
    1995 473 citations Benjamin L. Ebert et al. profile →
  18. Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation
    2017 473 citations Peter Grauman, Donna Neuberg et al. profile →
  19. Hypoxia and Mitochondrial Inhibitors Regulate Expression of Glucose Transporter-1 via Distinct Cis-acting Sequences
    1995 469 citations Benjamin L. Ebert et al. profile →
  20. Single-cell RNA-seq reveals changes in cell cycle and differentiation programs upon aging of hematopoietic stem cells
    2015 463 citations Dirk Heckl, Rebekka K. Schneider et al. profile →
  21. Oxygen-regulated control elements in the phosphoglycerate kinase 1 and lactate dehydrogenase A genes: similarities with the erythropoietin 3' enhancer.
    1994 458 citations Benjamin L. Ebert et al. profile →
  22. TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients
    2014 405 citations Rafael Bejar, Kristen E. Stevenson et al. Blood profile →
  23. The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia
    2016 374 citations Christopher J. Gibson, Benjamin L. Ebert et al. profile →
  24. The impact of the COVID-19 pandemic on cancer care
    2020 358 citations Benjamin L. Ebert et al. profile →
  25. Defining the human C2H2 zinc finger degrome targeted by thalidomide analogs through CRBN
    2018 341 citations Tarjei S. Mikkelsen, Benjamin L. Ebert et al. Science profile →
  26. Thalidomide promotes degradation of SALL4, a transcription factor implicated in Duane Radial Ray syndrome
    2018 312 citations Benjamin L. Ebert, Eric S. Fischer et al. profile →
  27. Distinction of lymphoid and myeloid clonal hematopoiesis
    2021 161 citations Abhishek Niroula, Alexander G. Bick et al. profile →
  28. Targeted protein degradation: from mechanisms to clinic
    2024 146 citations Benjamin L. Ebert, Eric S. Fischer et al. profile →
  29. Prediction of Risk for Myeloid Malignancy in Clonal Hematopoiesis
    2023 139 citations Lachelle D. Weeks, Abhishek Niroula et al. profile →
  30. Clonal Hematopoiesis of Indeterminate Potential Predicts Adverse Outcomes in Patients With Atherosclerotic Cardiovascular Disease
    2023 83 citations Art Schuermans, Md Mesbah Uddin et al. profile →
  31. Colchicine prevents accelerated atherosclerosis in TET2-mutant clonal haematopoiesis
    2024 36 citations Zhi Yu, Md Mesbah Uddin et al. profile →
  32. Clonal Hematopoiesis of Indeterminate Potential With Loss of Tet2 Enhances Risk for Atrial Fibrillation Through Nlrp3 Inflammasome Activation
    2024 35 citations Amy E. Lin, Abhishek Niroula et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Benjamin L. Ebert United States 78 46.7k 19.4k 14.2k 10.7k 9.5k 294 73.5k
Peter Carmeliet Belgium 151 53.1k 1.1× 27.4k 1.4× 8.2k 0.6× 15.0k 1.4× 11.7k 1.2× 729 100.0k
Pier Paolo Pandolfi United States 139 61.9k 1.3× 22.9k 1.2× 8.1k 0.6× 13.1k 1.2× 10.6k 1.1× 449 80.3k
Sean J. Morrison United States 92 32.4k 0.7× 11.6k 0.6× 12.8k 0.9× 21.7k 2.0× 10.1k 1.1× 183 62.4k
Judah Folkman United States 141 62.8k 1.3× 29.5k 1.5× 6.9k 0.5× 24.5k 2.3× 8.3k 0.9× 395 105.2k
Napoleone Ferrara United States 140 61.5k 1.3× 23.9k 1.2× 3.2k 0.2× 20.6k 1.9× 10.1k 1.1× 259 99.3k
Stuart H. Orkin United States 157 51.2k 1.1× 6.0k 0.3× 16.6k 1.2× 5.8k 0.5× 12.1k 1.3× 539 76.4k
Roderick T. Bronson United States 139 46.0k 1.0× 11.6k 0.6× 3.6k 0.3× 23.2k 2.2× 11.5k 1.2× 544 77.8k
Harvey F. Lodish United States 150 49.1k 1.1× 11.2k 0.6× 6.7k 0.5× 9.4k 0.9× 8.7k 0.9× 646 82.0k
Scott W. Lowe United States 123 50.1k 1.1× 16.9k 0.9× 3.4k 0.2× 23.0k 2.1× 8.5k 0.9× 325 69.6k
Stanley J. Korsmeyer United States 132 59.5k 1.3× 7.6k 0.4× 5.1k 0.4× 15.3k 1.4× 15.2k 1.6× 230 84.0k

Countries citing papers authored by Benjamin L. Ebert

Since Specialization
Citations

This map shows the geographic impact of Benjamin L. Ebert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin L. Ebert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin L. Ebert more than expected).

Fields of papers citing papers by Benjamin L. Ebert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin L. Ebert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin L. Ebert. The network helps show where Benjamin L. Ebert may publish in the future.

Co-authorship network of co-authors of Benjamin L. Ebert

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin L. Ebert. A scholar is included among the top collaborators of Benjamin L. Ebert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin L. Ebert. Benjamin L. Ebert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nardone, Christopher, Julian Mintseris, Justine C. Rutter, et al.. (2025). A heterotrimeric protein complex assembles the metazoan V-ATPase upon dissipation of proton gradients. Nature Structural & Molecular Biology. 32(10). 2076–2087. 1 indexed citations
2.
Schuermans, Art, Spencer Flynn, Abhishek Niroula, et al.. (2025). Clonal Hematopoiesis and Risk of New-Onset Myocarditis and Pericarditis. JAMA Cardiology. 10(11). 1147–1147. 3 indexed citations
3.
Hassan, Muhammad Murtaza, Yen-Der Li, W Michelle, et al.. (2024). Exploration of the tunability of BRD4 degradation by DCAF16 trans-labelling covalent glues. European Journal of Medicinal Chemistry. 279. 116904–116904. 12 indexed citations
4.
Yan, Chengcheng, Melissa A. Richard, Christopher J. Gibson, et al.. (2024). Clonal Hematopoiesis and Therapy-Related Myeloid Neoplasms After Autologous Transplant for Hodgkin Lymphoma. Journal of Clinical Oncology. 42(20). 2415–2424. 16 indexed citations
5.
Mueller, Jan, Christian Koch, Florin Schneiter, et al.. (2024). Targeting the mevalonate or Wnt pathways to overcome CAR T-cell resistance in TP53-mutant AML cells. EMBO Molecular Medicine. 16(3). 445–474. 16 indexed citations
6.
Saadatagah, Seyedmohammad, Md Mesbah Uddin, Lachelle D. Weeks, et al.. (2024). Clonal Hematopoiesis Risk Score and All-Cause and Cardiovascular Mortality in Older Adults. JAMA Network Open. 7(1). e2351927–e2351927. 19 indexed citations
7.
Schuermans, Art, Tetsushi Nakao, Yunfeng Ruan, et al.. (2023). Birth Weight Is Associated With Clonal Hematopoiesis of Indeterminate Potential and Cardiovascular Outcomes in Adulthood. Journal of the American Heart Association. 12(13). e030220–e030220. 4 indexed citations
8.
Castillo, Danielle, Bita Nehoray, Kai Yang, et al.. (2022). Clonal Hematopoiesis and Mosaicism Revealed by a Multi-Tissue Analysis of Constitutional TP53 Status. Cancer Epidemiology Biomarkers & Prevention. 31(8). 1621–1629. 7 indexed citations
9.
Ebert, Benjamin L. & Gunvor M. Kirkelund. (2022). Effects of Chlorides and Sulphates on Heavy Metal Leaching from Mortar with Raw and Electrodialytically Treated MSWI Fly Ash. Waste and Biomass Valorization. 13(5). 2673–2688. 12 indexed citations
10.
Sella, Tal, Geoffrey Fell, Peter G. Miller, et al.. (2022). Patient perspectives on testing for clonal hematopoiesis of indeterminate potential. Blood Advances. 6(24). 6151–6161. 8 indexed citations
11.
Boettcher, Steffen, C. Matthias Wilk, Jochen Singer, et al.. (2020). Clonal hematopoiesis in donors and long-term survivors of related allogeneic hematopoietic stem cell transplantation. Blood. 135(18). 1548–1559. 50 indexed citations
12.
Park, Sun‐Mi, Raquel P. Deering, Yuheng Lu, et al.. (2014). Musashi-2 controls cell fate, lineage bias, and TGF-β signaling in HSCs. The Journal of Experimental Medicine. 211(1). 71–87. 110 indexed citations
13.
Mullally, Ann, Claudia Bruedigam, Luke Poveromo, et al.. (2013). Depletion of Jak2V617F myeloproliferative neoplasm-propagating stem cells by interferon-α in a murine model of polycythemia vera. Blood. 121(18). 3692–3702. 126 indexed citations
14.
Shalem, Ophir, Neville E. Sanjana, Ella Hartenian, et al.. (2013). Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells. Science. 343(6166). 84–87. 3656 indexed citations breakdown →
15.
Looper, Ryan, Peppi Koivunen, Sung-Woo Lee, et al.. (2013). ( R )-2-Hydroxyglutarate Is Sufficient to Promote Leukemogenesis and Its Effects Are Reversible. Science. 339(6127). 1621–1625. 533 indexed citations breakdown →
16.
Krönke, Jan, Namrata D. Udeshi, Anupama Narla, et al.. (2013). Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells. Science. 343(6168). 301–305. 1288 indexed citations breakdown →
17.
Bejar, Rafael, Kristen E. Stevenson, Bennett Adam Caughey, et al.. (2012). Validation of a Prognostic Model and the Impact of Mutations in Patients With Lower-Risk Myelodysplastic Syndromes. Journal of Clinical Oncology. 30(27). 3376–3382. 312 indexed citations
18.
Zimmer, Michael, Justin Lamb, Benjamin L. Ebert, et al.. (2010). The Connectivity Map Links Iron Regulatory Protein-1–Mediated Inhibition of Hypoxia-Inducible Factor-2a Translation to the Anti-inflammatory 15-deoxy-Δ12,14-Prostaglandin J2. Cancer Research. 70(8). 3071–3079. 38 indexed citations
19.
Mullally, Ann & Benjamin L. Ebert. (2010). NF1 Inactivation Revs Up Ras in Adult Acute Myelogenous Leukemia. Clinical Cancer Research. 16(16). 4074–4076. 9 indexed citations
20.
Kim, William Y., Michal Safran, Benjamin L. Ebert, et al.. (2006). Failure to prolyl hydroxylate hypoxia‐inducible factor α phenocopies VHL inactivation in vivo. The EMBO Journal. 25(19). 4650–4662. 193 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter Carmeliet Breakdown of academic impact, for papers by Pier Paolo Pandolfi Breakdown of academic impact, for papers by Sean J. Morrison Breakdown of academic impact, for papers by Judah Folkman Breakdown of academic impact, for papers by Napoleone Ferrara Breakdown of academic impact, for papers by Stuart H. Orkin Breakdown of academic impact, for papers by Roderick T. Bronson Breakdown of academic impact, for papers by Harvey F. Lodish Breakdown of academic impact, for papers by Scott W. Lowe Breakdown of academic impact, for papers by Stanley J. Korsmeyer
Rankless by CCL
2026